These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 19203339)

  • 1. Alcohol and other drug treatment experiences of hepatitis C-positive and negative clients: implications for hepatitis C treatment.
    Brener L; Treloar CJ
    Aust Health Rev; 2009 Feb; 33(1):100-6. PubMed ID: 19203339
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prejudice among health care workers toward injecting drug users with hepatitis C: does greater contact lead to less prejudice?
    Brener L; von Hippel W; Kippax S
    Int J Drug Policy; 2007 Oct; 18(5):381-7. PubMed ID: 17854726
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Client and staff experiences of a co-located service for hepatitis C care in opioid substitution treatment settings in New South Wales, Australia.
    Treloar C; Rance J; Grebely J; Dore GJ
    Drug Alcohol Depend; 2013 Dec; 133(2):529-34. PubMed ID: 23932843
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of two community-controlled peer support services for assessment and treatment of hepatitis C virus infection in opioid substitution treatment clinics: The ETHOS study, Australia.
    Treloar C; Rance J; Bath N; Everingham H; Micallef M; Day C; Hazelwood S; Grebely J; Dore GJ
    Int J Drug Policy; 2015 Oct; 26(10):992-8. PubMed ID: 25697089
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Uptake and delivery of hepatitis C treatment in opiate substitution treatment: perceptions of clients and health professionals.
    Treloar C; Newland J; Rance J; Hopwood M
    J Viral Hepat; 2010 Dec; 17(12):839-44. PubMed ID: 20070504
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Knowledge and attitudes towards hepatitis C and injecting drug use among mental-health support workers of a community managed organisation.
    Rose G; Cama E; Brener L; Treloar C
    Aust Health Rev; 2013 Nov; 37(5):654-9. PubMed ID: 24160716
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Influence of hepatitis C status on alcohol consumption in opiate users in treatment.
    McCusker M
    Addiction; 2001 Jul; 96(7):1007-14. PubMed ID: 11440611
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Barriers to enrollment in drug abuse treatment and suggestions for reducing them: opinions of drug injecting street outreach clients and other system stakeholders.
    Appel PW; Ellison AA; Jansky HK; Oldak R
    Am J Drug Alcohol Abuse; 2004; 30(1):129-53. PubMed ID: 15083558
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of Government and Non-Government Alcohol and Other Drug (AOD) Treatment Service Delivery for the Lesbian, Gay, Bisexual, and Transgender (LGBT) Community.
    Mullens AB; Fischer J; Stewart M; Kenny K; Garvey S; Debattista J
    Subst Use Misuse; 2017 Jul; 52(8):1027-1038. PubMed ID: 28318357
    [TBL] [Abstract][Full Text] [Related]  

  • 10. How to build trustworthy hepatitis C services in an opioid treatment clinic? A qualitative study of clients and health workers in a co-located setting.
    Treloar C; Rance J;
    Int J Drug Policy; 2014 Sep; 25(5):865-70. PubMed ID: 24559604
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Non-injection drug use and hepatitis C among drug treatment clients in west central Mexico.
    Campollo O; Roman S; Panduro A; Hernandez G; Diaz-Barriga L; Balanzario MC; Cunningham JK
    Drug Alcohol Depend; 2012 Jun; 123(1-3):269-72. PubMed ID: 22138538
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The politics of place(ment): problematising the provision of hepatitis C treatment within opiate substitution clinics.
    Rance J; Newland J; Hopwood M; Treloar C
    Soc Sci Med; 2012 Jan; 74(2):245-53. PubMed ID: 22133583
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Alcohol and drug treatment population profile: a comparison of 1998 and 2004 data in New Zealand.
    Adamson S; Sellman D; Deering D; Robertson P; de Zwart K
    N Z Med J; 2006 Oct; 119(1244):U2284. PubMed ID: 17072359
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Correlates of drug treatment program staff's self efficacy to support their clients' hepatitis C virus (HCV) related needs.
    Strauss SM; Astone-Twerell JM; Munoz-Plaza C; Des Jarlais DC; Gwadz M; Hagan H; Osborne A; Rosenblum A
    Am J Drug Alcohol Abuse; 2007; 33(2):245-51. PubMed ID: 17497547
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Assessing the validity of the Australian Treatment Outcomes Profile for telephone administration in drug health treatment populations.
    Deacon RM; Mammen K; Holmes J; Dunlop A; Bruno R; Mills L; Graham R; Lintzeris N
    Drug Alcohol Rev; 2020 Jul; 39(5):441-446. PubMed ID: 32395850
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Discrimination by health care workers versus discrimination by others: countervailing forces on HCV treatment intentions.
    Brener L; Horwitz R; von Hippel C; Bryant J; Treloar C
    Psychol Health Med; 2015; 20(2):148-53. PubMed ID: 24889417
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ordering clinical realities: Controversy and multiplicity in alcohol and other drug treatment for young adults.
    Hart A
    Int J Drug Policy; 2018 Feb; 52():79-86. PubMed ID: 29272742
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Smoking cessation care provision in Australian alcohol and other drug treatment services: A cross-sectional survey of staff self-reported practices.
    Skelton E; Tzelepis F; Shakeshaft A; Guillaumier A; Dunlop A; McCrabb S; Palazzi K; Bonevski B
    J Subst Abuse Treat; 2017 Jun; 77():101-106. PubMed ID: 28476261
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Staff perspectives on facilitating the implementation of hepatitis C services at drug treatment programs.
    Munoz-Plaza CE; Strauss SM; Astone-Twerwll JM; Des Jarlais DC; Hagan H
    J Psychoactive Drugs; 2006 Sep; 38(3):233-41. PubMed ID: 17165366
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Relative importance of abstinence in clients' and clinicians' perspectives of recovery from drug and alcohol abuse.
    Maffina L; Deane FP; Lyons GC; Crowe TP; Kelly PJ
    Subst Use Misuse; 2013 Jun; 48(9):683-90. PubMed ID: 23627679
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.